Skip to main content
Orthopedic Biomaterials Market by Application and Geography - Forecast and Analysis 2020-2024

Orthopedic Biomaterials Market by Application and Geography - Forecast and Analysis 2020-2024

Published: Dec 2020 120 Pages SKU: IRTNTR45757

Orthopedic Biomaterials Market Report 2020-2024

The orthopedic biomaterials market size has the potential to grow by USD 8.3 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period.

Browse TOC and LoE with selected illustrations and example pages of Orthopedic Biomaterials Market

Request a FREE sample now!

Orthopedic Biomaterials Market: Segmentation by Geography

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. North America will offer several growth opportunities to market vendors during the forecast period. The increasing use of nanoparticles in orthopedic bioimplants, increasing focus on customizing material properties, and rise in healthcare expenditure will significantly influence orthopedic biomaterials market growth in this region.

60% of the market's growth will originate from North America during the forecast period. The US is a key market for orthopedic biomaterials in North America. This report provides an accurate prediction of the contribution of all segments to the growth of the orthopedic biomaterials market size.

Market Competitive Analysis

The orthopedic biomaterials market is fragmented. B. Braun Melsungen AG, CONMED Corp., and Evonik Industries AG are some of the major market participants. Factors such as the increasing prevalence of musculoskeletal diseases and disorders, increasing number of joint replacement and arthroplasty surgeries, and advances in orthopedic biomaterials will offer immense growth opportunities. However, high cost of orthopedic bioimplants and surgeries, drawbacks of orthopedic biomaterials, and stringent regulations may impede market growth. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this orthopedic biomaterials market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and offers information on the products offered by various companies. Moreover, this orthopedic biomaterials market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

  • B. Braun Melsungen AG
  • CONMED Corp.
  • Evonik Industries AG
  • Johnson & Johnson
  • Koninklijke DSM NV
  • Medtronic Plc
  • Smith & Nephew Plc
  • Stryker Corp.
  • Victrex Plc
  • Zimmer Biomet Holdings Inc.

Orthopedic Biomaterials Market: Key Highlights of the Report for 2020-2024

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that drive will orthopedic biomaterials market growth during the next five years
  • Precise estimation of the orthopedic biomaterials market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the orthopedic biomaterials industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of orthopedic biomaterials market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Orthopedic Biomaterials market growth will increase by 8298.44 million during 2019-2024.

The Orthopedic Biomaterials market is expected to grow at a CAGR of 5.77% during 2019-2024.

Orthopedic Biomaterials market is segmented by Application( Joint replacement, Osteosynthesis, Orthobiologics, Spine implants) Geographic( North America, Europe, Asia, ROW)

B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG, Johnson & Johnson, Koninklijke DSM NV, Medtronic Plc, Smith & Nephew Plc, Stryker Corp., Victrex Plc, Zimmer Biomet Holdings Inc. are a few of the key vendors in the Orthopedic Biomaterials market.

North America will register the highest growth rate of 60.49% among the other regions. Therefore, the Orthopedic Biomaterials market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Germany, France, Japan, UK, China

  • Increasing prevalence of musculoskeletal diseases and disorders is the driving factor this market.

The Orthopedic Biomaterials market vendors should focus on grabbing business opportunities from the Joint replacement segment as it accounted for the largest market share in the base year.